abstract |
A pharmaceutical composition exhibiting anti-tumor activity, the composition comprising less than 10%, by weight, of a toluene sulfonamide and a pharmaceutically acceptable aqueous carrier selected from the group consisting of an injectable carrier, an infusible carrier and a palatable orally-administrable carrier. |